AngioDynamics is headquartered in Latham, US

AngioDynamics has offices in Latham, Amsterdam-Zuidoost, Oakville, Hong Kong and in 1 other location

Latham, US (HQ)

14 Plaza Dr

Denmead, GB

Falcon Court Forest Rd

Hong Kong, HK

72 Gloucester Rd

Oakville, CA

101 2275 Upper Middle Rd E

Amsterdam-Zuidoost, NL

Margriet Toren 75 Haaksbergweg

AngioDynamics's revenue was reported to be $353.9 m in FY, 2016

USD

## Revenue (FY, 2016) | 353.9 m |

## Revenue growth (FY, 2015 - FY, 2016), % | (1%) |

## Gross profit (FY, 2016) | 174.3 m |

## Gross profit margin (FY, 2016), % | 49% |

## Net income (FY, 2016) | (43.6 m) |

## EBIT (FY, 2016) | 1 m |

## Market capitalization (18-Aug-2017) | 632 m |

## Cash (31-May-2016) | 32.3 m |

## EV | 721.1 m |

AngioDynamics's current market capitalization is $632 m.

USD | FY, 2014^{} | FY, 2015^{} | FY, 2016^{} |
---|---|---|---|

## Revenue | 354.5 m | 357 m | 353.9 m |

## Revenue growth, % | 1% | (1%) | |

## Cost of goods sold | 174.6 m | 180.1 m | 179.6 m |

## Gross profit | 179.9 m | 176.9 m | 174.3 m |

## Gross profit Margin, % | 51% | 50% | 49% |

## Sales and marketing expense | 84.7 m | ||

## R&D expense | 25.1 m | ||

## General and administrative expense | 29.6 m | ||

## Operating expense total | 166.4 m | 177.9 m | 173.3 m |

## EBIT | 13.4 m | (994 k) | 1 m |

## EBIT margin, % | 4% | (0%) | 0% |

## Interest expense | 3.7 m | 3.2 m | 3.4 m |

## Interest income | 4 k | 11 k | |

## Income tax expense | 3.3 m | (4.7 m) | 40.3 m |

## Net Income | 3.1 m | (3.3 m) | (43.6 m) |

USD | Q1, 2014^{} | Q2, 2014^{} | Q3, 2015^{} | Q1, 2015^{} | Q2, 2015^{} | Q3, 2016^{} |
---|---|---|---|---|---|---|

## Revenue | 83.7 m | 89.2 m | 87.4 m | |||

## Cost of goods sold | 40.5 m | 43.4 m | 43.9 m | |||

## Gross profit | 43.2 m | 45.8 m | 43.5 m | |||

## Gross profit Margin, % | 52% | 51% | 50% | |||

## Sales and marketing expense | 20.6 m | 20.6 m | 20.3 m | |||

## R&D expense | 6.2 m | 6.2 m | 5.8 m | |||

## General and administrative expense | 7.4 m | 8.1 m | 6.8 m | |||

## Operating expense total | 34.2 m | 34.8 m | 32.9 m | |||

## EBIT | 1.1 m | 1.3 m | 2.7 m | |||

## EBIT margin, % | 1% | 1% | 3% | |||

## Interest expense | (800 k) | (998 k) | (809 k) | |||

## Interest income | 1 k | 1 k | 2 k | |||

## Income tax expense | 83 k | (366 k) | 382 k | |||

## Net Income | 470 k | 1.8 m | (2.5 m) | (757 k) | (1.1 m) | (489 k) |

USD | FY, 2014^{} | FY, 2015^{} | FY, 2016^{} |
---|---|---|---|

## Cash | 16.1 m | 18.4 m | 32.3 m |

## Inventories | 61.1 m | 67.4 m | 55.4 m |

## Current Assets | 152.2 m | 155.8 m | 146.3 m |

## PP&E | 67.2 m | 54.6 m | 48.3 m |

## Goodwill | 360.3 m | 361.3 m | 361.3 m |

## Total Assets | 800.2 m | 773.6 m | 727.1 m |

## Accounts Payable | 32.9 m | 23.7 m | 15.6 m |

## Total Debt | 137.7 m | 121.4 m | |

## Current Liabilities | 72.3 m | 61.2 m | 66.7 m |

## Total Liabilities | 219.8 m | ||

## Additional Paid-in Capital | 508.3 m | 520.1 m | 525.8 m |

## Retained Earnings | 32.7 m | 28.2 m | (16 m) |

## Total Equity | 545 m | 507.2 m | |

## Debt to Equity Ratio | 0.3 x | 0.2 x | |

## Debt to Assets Ratio | 0.2 x | 0.2 x | |

## Financial Leverage | 1.4 x | 1.4 x |

USD | Q1, 2014^{} | Q2, 2014^{} | Q3, 2015^{} | Q1, 2015^{} | Q2, 2015^{} | Q3, 2016^{} |
---|---|---|---|---|---|---|

## Cash | 13.8 m | 14.9 m | 19.7 m | 20.3 m | 19 m | 21.9 m |

## Inventories | 70.4 m | 75.3 m | 68.7 m | 74.3 m | 70.8 m | 65.8 m |

## Current Assets | 154.3 m | 163.4 m | 157.3 m | 160 m | 151.6 m | 149.4 m |

## PP&E | 51.2 m | 49.7 m | ||||

## Goodwill | 360.5 m | 360.5 m | 360.5 m | 361.3 m | 361.3 m | 361.3 m |

## Total Assets | 796.1 m | 799.3 m | 783.1 m | 771.8 m | 760.4 m | 753.5 m |

## Accounts Payable | 29.3 m | 22 m | 21.7 m | 24.9 m | 21.7 m | 18.1 m |

## Current Liabilities | 63.7 m | 57.9 m | 59.7 m | 60.7 m | 60.1 m | 61.6 m |

## Additional Paid-in Capital | 510.7 m | 513.4 m | 518.3 m | 523 m | 524.2 m | 526.5 m |

## Retained Earnings | 32 m | 33.3 m | 29 m | 27.5 m | 27.1 m | 27.7 m |

## Total Equity | 547.1 m | 547.6 m | 550.7 m | |||

## Financial Leverage | 1.4 x | 1.4 x | 1.4 x |

USD | FY, 2014^{} | FY, 2015^{} | FY, 2016^{} |
---|---|---|---|

## Net Income | 3.1 m | (3.3 m) | (43.6 m) |

## Depreciation and Amortization | 16.8 m | 17.9 m | 18 m |

## Accounts Receivable | (15 m) | 2.1 m | 3.1 m |

## Inventories | (5.4 m) | (6.2 m) | 12 m |

## Cash From Operating Activities | 25.3 m | 26.2 m | 45.2 m |

## Purchases of PP&E | (11.8 m) | (11.9 m) | (2.3 m) |

## Cash From Investing Activities | (17 m) | (13.3 m) | (7.6 m) |

## Long-term Borrowings | (146.3 m) | (20 m) | (16.3 m) |

## Cash From Financing Activities | (14 m) | (10.5 m) | (23.7 m) |

## Interest Paid | 3.6 m | 3.2 m | 3.1 m |

## Income Taxes Paid | 182 k | 699 k | 332 k |

USD | Q1, 2014^{} | Q2, 2014^{} | Q3, 2015^{} | Q1, 2015^{} | Q2, 2015^{} | Q3, 2016^{} |
---|---|---|---|---|---|---|

## Net Income | 470 k | 1.8 m | (2.5 m) | (757 k) | (1.1 m) | (489 k) |

## Depreciation and Amortization | 6.7 m | 14 m | 22.8 m | 7.2 m | 14.4 m | 21.4 m |

## Accounts Receivable | 5.8 m | 3.1 m | 3.5 m | 5.9 m | 4.9 m | 2.5 m |

## Inventories | (9.2 m) | (14.1 m) | (7.5 m) | (6.9 m) | (3.5 m) | 1.5 m |

## Cash From Operating Activities | 5.4 m | 3.2 m | 15.4 m | 4.7 m | 14.3 m | 26.7 m |

## Purchases of PP&E | (5.1 m) | (7.5 m) | (11 m) | (743 k) | (1.2 m) | (1.9 m) |

## Cash From Investing Activities | (5.3 m) | (7.8 m) | (12 m) | (743 k) | (1.1 m) | (3.9 m) |

## Long-term Borrowings | (1.3 m) | (2.5 m) | (8.8 m) | (1.3 m) | (3.8 m) | (11.3 m) |

## Cash From Financing Activities | (2.4 m) | 3.4 m | 641 k | (2.1 m) | (12.4 m) | (19.2 m) |

USD | Y, 2016 |
---|---|

## EV/EBIT | 708.3 x |

## EV/CFO | 15.9 x |

## Revenue/Employee | 272.2 k |

## Debt/Equity | 0.2 x |

## Debt/Assets | 0.2 x |

## Financial Leverage | 1.4 x |